Annual Neuromuscular Postdoctoral Research and Clinical Fellowships Funding Competition Now Open

Together with Muscular Dystrophy Canada (MDC) and the Canadian Society of Clinical Neurophysiologists we are excited to announce the opening of our 2024 annual funding competition to award postdoctoral fellowships in neuromuscular disease (NMD) research, and clinical fellowship awards in neuromuscular medicine and electromyography! 

This annual funding competition provides salary support for early-career scientists to conduct postdoctoral studies in a laboratory focused on research of NMDs, and early-career clinicians to participate in a neuromuscular medicine and electromyography fellowship training program. Successful applicants are eligible to receive $40 000 in funding over a one-year period for a postdoctoral fellowship, and $80 000 in funding over a one-year period for a clinical fellowship.

Dates and Timelines

Funding competition opens: Today, September 5th, 2023 

Application submission deadline: Tuesday October 17th, 2023. 

Eligibility and Selection Criteria

The 2024 competition guidelines available on the NMD4C website for updated information on the 2024 competition guidelines for both the postdoctoral research fellowship and clinical fellowships, as well as information on how to submit your application.

Postdoctoral fellowship competition guidelines

Clinical fellowship competition guidelines

If you have any questions about the 2024 competition, please contact network manager Erin Beattie at .

MDC, NMD4C and CSCN fellowships competition is now open

Read next...

AGAMREE (vamorolone) Approved treatment for DMD in Canada

A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada

Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.

Website - SBMA published on CMAJ.png

New Best Practice Recommendations for SBMA Care in Canada

Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!

2025 NMD4C ANNUAL MEETING

Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting

On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.

2025 Clinical Summer School

NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders

On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.

2026 Neuromuscular Postdoc Research Fellowship Competition

2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!

Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)

Clinical Fellowship Awardees

Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients

We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.